StockData
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd (CLGN) stock

CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.96+0.06 (+1.54%)

Close on Nov 11, 2026Market cap $5.72MP/E –Yield –

CollPlant Biotechnologies revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $2.37M, up 360.4% from the year before. The highest annual figure on record is $15.64M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.37M+360.4%
FY2024Dec 31, 2024$515.00K-95.3%
FY2023Dec 31, 2023$10.96M+3565.2%
FY2022Dec 31, 2022$299.00K-98.1%
FY2021Dec 31, 2021$15.64M+154.9%
FY2020Dec 31, 2020$6.14M+164.8%
FY2019Dec 31, 2019$2.32M-53.8%
FY2018Dec 31, 2018$5.01M+982.9%
FY2017Dec 31, 2017$463.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2025Jun 30, 2025$179.00K-74.1%
Q2 FY2024Jun 30, 2024$249.00K-69.7%
Q2 FY2023Jun 30, 2023$10.18M+1580.5%
Q2 FY2022Jun 30, 2022$66.00K-63.7%
Q2 FY2021Jun 30, 2021$691.00K–
Q2 FY2020Jun 30, 2020$823.00K–
Q2 FY2019Jun 30, 2019$606.00K–
Q2 FY2018Jun 30, 2018$182.00K–

More CollPlant Biotechnologies figures

See a number that looks wrong?